Modulation of the Nrf2 Signaling Pathway by Chemopreventive Dietary Phytoconstituents

Chapter

Abstract

Epidemiological studies have revealed the healing power of a diet rich in fruits and vegetables in both the prevention and amelioration of chronic illness. Chemoprevention, utilizing dietary agents, has been suggested as a fascinating strategy in the fight against cancer. Dietary phytoconstituents, such as carotenoids, polyphenols and organosulfur compounds, present in a multitude of dietary sources have been shown to possess potent antioxidant and anti-inflammatory properties as well as the ability to modulate a multitude of signaling mechanisms. Oxidative stress is a key element of the pathogenesis of neoplastic diseases and its attenuation is a vital step in the chemopreventive strategy. The nuclear factor-erythroid 2-related factor 2 (Nrf2)-mediated signaling pathway is the primary antioxidant mechanism in nature and thus an extremely critical element of the chemopreventive strategy. This chapter highlights the Nrf2-modulating property of dietary phytoconstituents in their ability to afford chemoprevention against a multitude of neoplastic diseases. This article provides a brief explanation of the Nrf-2 signaling pathway, its antioxidant effects and its role in the chemoprevention as well as amelioration of neoplastic disorders. Essentially reviewed are studies which elucidate pharmacological effects of select dietary phytochemicals in pre-clinical models of cancer with special emphasis on their Nrf2 modulating properties. The article also highlights the current status of progress entailed in the development of the Nrf2 modulation pathway using dietary phytonutrients as a robust chemopreventive strategy with practical significance in the clinic.

Keywords

Chemopreventive Agent Organosulfur Compound Nrf2 Pathway Nrf2 Signaling Dietary Agent 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Notes

Acknowledgments

Our research on chemoprevention of liver cancer by modulation of Nrf2 pathway by several dietary phytoconstituents as described in this chapter was carried out at the Northeast Ohio Medical University (Rootstown, OH) supported by Research Incentive Grant from the Ohio Board of Regents and a New Faculty Start-Up Research Grant to A.B. The authors sincerely thank Animesh Mandal, Ph.D., for assistance with the bibliographic work and Werner J. Geldenhuys, Ph.D., for technical assistance with the illustration (Fig. 20.1).

References

  1. Bansal SS, Goel M, Aqil F, Vadhanam MV et al (2011) Advanced drug delivery systems of curcumin for cancer chemoprevention. Cancer Prev Res 8:1158–1171CrossRefGoogle Scholar
  2. Becks L, Prince M, Burson H, Christophe C et al (2010) Aggressive mammary carcinoma progression in Nrf2 knockout mice treated with 7,12-dimethylbenz[a]anthracene. BMC Cancer 10:540PubMedCrossRefGoogle Scholar
  3. Ben-Dor A, Steiner M, Gheber L, Danilenko M et al (2005) Carotenoids activate the antioxidant response element transcription system. Mol Cancer Ther 4:177–186PubMedGoogle Scholar
  4. Benson AM, Batzinger RP, Ou SY, Bueding E et al (1978) Elevation of hepatic glutathione S-transferase activities and protection against mutagenic metabolites of benzo(a)pyrene by dietary antioxidants. Cancer Res 38:4486–4495PubMedGoogle Scholar
  5. Benson AM, Hunkeler MJ, Talalay P (1980) Increase of NAD(P)H:quinone reductase by dietary antioxidants: possible role in protection against carcinogenesis and toxicity. Proc Natl Acad Sci U S A 77:5216–5220PubMedCrossRefGoogle Scholar
  6. Bishayee A, Dhir N (2009) Resveratrol-mediated chemoprevention of diethylnitrosamine-initiated hepatocarcinogenesis: inhibition of cell proliferation and induction of apoptosis. Chem Biol Interact 179:131–144PubMedCrossRefGoogle Scholar
  7. Bishayee A, Waghray A, Barnes KF, Mbimba T et al (2010a) Suppression of the inflammatory cascade is implicated in resveratrol chemoprevention of experimental hepatocarcinogenesis. Pharm Res 27:1080–1091PubMedCrossRefGoogle Scholar
  8. Bishayee A, Barnes KF, Bhatia D, Darvesh AS et al (2010b) Resveratrol suppresses oxidative stress and inflammatory response in diethylnitrosamine-initiated rat hepatocarcinogenesis. Cancer Prev Res 3:753–763CrossRefGoogle Scholar
  9. Bishayee A, Bhatia D, Thoppil RJ, Darvesh AS et al (2011) Pomegranate-mediated chemoprevention of experimental hepatocarcinogenesis involves Nrf2-regulated mechanisms. Carcinogenesis 32:888–896PubMedCrossRefGoogle Scholar
  10. Cha YN, Heine S (1982) Comparative effects of dietary administration of 2(3)-tert-butyl-4-hydroxyanisole and 3,5-di-tert-butyl-4-hydroxytoluene on several hepatic enzyme activities in mice and rats. Cancer Res 42:2609–2615PubMedGoogle Scholar
  11. Chen C, Pung D, Leong V, Hebber V et al (2004) Induction of detoxifying enzymes by garlic organosulfur compounds through transcription factor Nrf2: effect of chemical structure and stress signals. Free Radic Biol Med 37:1578–1590PubMedCrossRefGoogle Scholar
  12. Chen CY, Jang JH, Li MH, Surh YJ (2005) Resveratrol upregulates heme oxygenase-1 expression via activation of NF-E2-related factor in PC12 cells. Biochem Biophys Res Commun 331:993–1000PubMedCrossRefGoogle Scholar
  13. Cheung KL, Kong AL (2010) Molecular targets of dietary phenethyl isothiocyanate and sulforaphane for cancer chemoprevention. AAPS J 12:87–97PubMedCrossRefGoogle Scholar
  14. Cheung KL, Khor TO, Huang MT, Kong AH (2010) Differential in vivo mechanism of chemoprevention of tumor formation in azoxymethane/dextran sodium sulfate mice by PEITC and DBM. Carcinogenesis 31:880–885PubMedCrossRefGoogle Scholar
  15. Chiou YS, Tsai ML, Nagabhushanam K, Wang YJ et al (2011) Pterostilbene is more potent that resveratrol in preventing azoxymethane (AOM)-induced colon tumorigenesis via activation of the NF-E2-related factor (Nrf2)-mediated antioxidant signaling pathway. J Agric Food Chem 59:2725–2733PubMedCrossRefGoogle Scholar
  16. Cooke MS, Evans MD, Evans M, Dizdaroglu M et al (2003) Oxidative DNA damage: mechanisms, mutation, and disease. FASEB J 17:1195–1214PubMedCrossRefGoogle Scholar
  17. Darvesh AS, Aggarwal BB, Bishayee A (2011) Curcumin and liver cancer: a review. Curr Pharm Biotechnol (In press). PMID: 21466422Google Scholar
  18. Del Rio D, Borges G, Crozier A (2010) Berry flavonoids and phenolics: bioavailability and evidence of protective effects. Br J Nutr 104:S67–S90PubMedCrossRefGoogle Scholar
  19. Ding M, Zhao J, Bowman L, Lu Y et al (2010) Inhibition of AP-1 and MAPK signaling and activation of Nrf2/ARE pathway by quercitrin. Int J Oncol 36:59–67PubMedGoogle Scholar
  20. Eggler AL, Gay KA, Mesecar AD (2008) Molecular mechanisms of natural products in chemoprevention: induction of cytoprotective enzymes by Nrf2. Mol Nutr Food Res 52:S84–S94PubMedGoogle Scholar
  21. Eussen SR, Verhagen H, Klungel OH et al (2011) Functional foods and dietary supplements: products at the interface between pharma and nutrition. Eur J Pharmacol 668:S2–S9, PMID: 21816140PubMedCrossRefGoogle Scholar
  22. Faria A, Monteiro R, Mateus N, Azevedo I et al (2007) Effect of pomegranate (Punica granatum) juice intake on hepatic oxidative stress. Eur J Nutr 46:271–278PubMedCrossRefGoogle Scholar
  23. Farombi EO, Shrotriya S, Na HK, Kim SH et al (2008) Curcumin attenuates dimethylnitrosamine-induced liver injury in rats through Nrf2-mediated induction of heme oxygenase-1. Food Chem Toxicol 46:1279–1287PubMedCrossRefGoogle Scholar
  24. Garg R, Gupta S, Maru GB (2008) Dietary curcumin modulates transcriptional regulators of phase I and phase II enzymes in benzo[a]pyrene-treated mice: mechanism of its anti-initiating action. Carcinogenesis 29:1022–1032PubMedCrossRefGoogle Scholar
  25. Gerhäuser C, Klimo K, Hümmer W, Hölzer J et al (2009) Identification of 3-hydroxy-beta-damascone and related carotenoid-derived aroma compounds as novel potent inducers of Nrf2-mediated phase 2 response with concomitant anti-inflammatory activity. Mol Nutr Food Res 53:1237–1244PubMedCrossRefGoogle Scholar
  26. Gil MI, Tomas-Barberan FA, Hess-Pierce B, Holcroft DM et al (2000) Antioxidant activity of pomegranate juice and its relationship with phenolic composition and processing. J Agric Food Chem 48:4581–4589PubMedCrossRefGoogle Scholar
  27. Goodman M, Bostick RM, Kucuk O, Jones DP (2011) Clinical trials of antioxidants as cancer prevention agents. Free Radic Biol Med 51(5):1068–1084, PMID: 21683786PubMedCrossRefGoogle Scholar
  28. Granado-Serrano AB, Martín MA, Haegeman G, Goya L et al (2010) Epicatechin induces NF-kappaB, activator protein-1 (AP-1) and nuclear transcription factor erythroid 2p45-related factor-2 (Nrf2) via phosphatidylinositol-3-kinase/protein kinase B (PI3K/AKT) and extracellular regulated kinase (ERK) signalling in HepG2 cells. Br J Nutr 103:168–179PubMedCrossRefGoogle Scholar
  29. Ha HL, Shin HJ, Feitelson MA, Yu DY (2010) Oxidative stress and antioxidants in hepatic pathogenesis. World J Gastroenterol 16:6035–6043PubMedCrossRefGoogle Scholar
  30. Hayes JD, McMahon M (2001) Molecular basis for the contribution of the antioxidant response element to cancer chemoprevention. Cancer Lett 174:103–113PubMedCrossRefGoogle Scholar
  31. Hayes JD, McMahon M, Chowdhry S, Dinkova-Kostova AT (2010) Cancer chemoprevention mechanisms mediated through the Keap1-Nrf2 pathway. Antioxid Redox Signal 13:1713–1748PubMedCrossRefGoogle Scholar
  32. Hsieh TC, Lu X, Wang Z, Wu JM (2006) Induction of quinone reductase NQO1 by resveratrol in human K562 cells involves the antioxidant response element ARE and is accompanied by nuclear translocation of transcription factor Nrf2. Med Chem 2:275–285PubMedCrossRefGoogle Scholar
  33. Hu R, Xu SG, Jain MR et al (2006a) Identification of Nrf2-regulated genes induced by chemopreventive isothiocyanate PETIC by oligonucleotide microarray. Life Sci 79:1944–1955PubMedCrossRefGoogle Scholar
  34. Hu R, Xu C, Shen G, Jain MR et al (2006b) Gene expression profiles induced by cancer chemopreventive isothiocyanate sulforaphane in the liver of C57BL/6J mice and C57BL/gJ/Nrf2 (-/-) mice. Cancer Lett 243:170–192PubMedCrossRefGoogle Scholar
  35. Hu R, Constance LS, Yu R, Kong AT (2010) Regulation of NF-E2-related factor 2 signaling for cancer chemoprevention: antioxidant coupled with anti-inflammatory. Antioxid Redox Signal 13:1679–1698PubMedCrossRefGoogle Scholar
  36. Jeong WS, Keum YS, Chen C, Jain MR et al (2005) Differential expression and stability of endogenous nuclear factor E2-related factor 2 (Nrf2) by natural chemopreventive compounds in HepG2 human hepatoma cells. J Biochem Mol Biol 38:167–176PubMedCrossRefGoogle Scholar
  37. Johnson J, de Meija EG (2011) Dietary factors and pancreatic cancer: the role of food bioactive compounds. Mol Nutr Food Res 55:58–73PubMedCrossRefGoogle Scholar
  38. Joung EJ, Li MH, Lee HG, Somparn N et al (2007) Capsaicin induces heme oxygenase-1 expression in HepG2 cells via activation of PI3K-Nrf2 signaling: NAD(P)H:Quinone oxidoreductase as a potential target. Antioxid Redox Signal 9:2087–2098PubMedCrossRefGoogle Scholar
  39. Kalthoff S, Ehmer U, Freiberg N, Manns MP et al (2010) Coffee induces expression of glucuronosyltransferases by the aryl hydrocarbon receptor and Nrf2 in liver and stomach. Gastroenterology 139:1699–1710PubMedCrossRefGoogle Scholar
  40. Kang NJ, Shin SH, Lee HJ, Lee KW (2011) Polyphenols as small molecular inhibitors of signaling cascades in carcinogenesis. Pharmacol Ther 130:310–324PubMedCrossRefGoogle Scholar
  41. Kawanishi S, Hiraku Y, Pinlaor S, Ma N (2006) Oxidative and nitrative DNA damage in animals and patients with inflammatory diseases in relation to inflammation-related carcinogenesis. Biol Chem 387:365–372PubMedCrossRefGoogle Scholar
  42. Kelloff GJ, Sigman CC, Greenwald P (1999) Cancer chemoprevention: progress and promise. Eur J Cancer 35:1755–1762PubMedCrossRefGoogle Scholar
  43. Kensler TW, Wakabayashi N (2010) Nrf2: friend or foe of chemoprevention? Carcinogenesis 31:90–99PubMedCrossRefGoogle Scholar
  44. Keum YS, Owner ED, Kim BR, Hu R et al (2003) Involvement of Nrf2 and JNK1 in the activation of antioxidant responsive element (ARE) by chemopreventive agent phenethyl isothiocyanate (PETIC). Pharm Res 20:1351–1356PubMedCrossRefGoogle Scholar
  45. Khor TO, Yu S, Kong AH (2008) Dietary cancer chemopreventive agents – targeting inflammation and Nrf2 signaling pathway. Planta Med 74:1540–1547PubMedCrossRefGoogle Scholar
  46. Klaassen CD, Reisman SA (2010) Nrf2 the rescue: effects of the antioxidative/electrophilic response on the liver. Toxicol Appl Pharmacol 244:57–65PubMedCrossRefGoogle Scholar
  47. Klaunig JE, Kamendulis LM (2004) The role of oxidative stress in carcinogenesis. Annu Rev Pharmacol Toxicol 44:239–267PubMedCrossRefGoogle Scholar
  48. Kode A, Rajendrasozhan S, Caito S, Yang SR et al (2008) Resveratrol induces glutathione synthesis by activation of Nrf2 and protects against cigarette smoke-mediated oxidative stress in human lung epithelial cells. Am J Physiol Lung Cell Mol Physiol 294:L478–L488PubMedCrossRefGoogle Scholar
  49. Kong AN, Yu R, Hebbar V, Chen C et al (2001) Signal transduction events elicited by cancer prevention compounds. Mutat Res 480–481:231–241PubMedGoogle Scholar
  50. Kundu JK, Surh YJ (2010) Nrf2-Keap1 signaling as a potential target for chemoprevention of inflammation-associated carcinogenesis. Pharm Res 27:999–1013PubMedCrossRefGoogle Scholar
  51. Kwon KH, Barve A, Yu S et al (2007) Cancer chemoprevention by phytochemicals: potential molecular targets, biomarkers and animal models. Acta Pharmacol Sin 28:1409–1421PubMedCrossRefGoogle Scholar
  52. Lansky EP, Newman RA (2007) Punica granatum (pomegranate) and its potential for prevention and treatment of inflammation and cancer. J Ethnopharmacol 109:177–206PubMedCrossRefGoogle Scholar
  53. Lawless MW, O'Byrne KJ, Gray SG (2010) Targeting oxidative stress in cancer. Expert Opin Ther Targets 14:1225–1245PubMedCrossRefGoogle Scholar
  54. Lee JS, Surh YJ (2005) Nrf2 as a novel molecular target for chemoprevention. Cancer Lett 224:171–184PubMedCrossRefGoogle Scholar
  55. Lee SB, Kim CY, Lee HJ, Yun JH et al (2009) Induction of the phase II detoxification enzyme NQO1 in hepatocarcinoma cells by lignans from the fruit of Schisandra chinensis through nuclear accumulation of Nrf2. Planta Med 75:1314–1318PubMedCrossRefGoogle Scholar
  56. Li W, Kong AN (2009) Molecular mechanisms of Nrf2-mediated antioxidant response. Mol Carcinog 48:91–104PubMedCrossRefGoogle Scholar
  57. Li W, Khor TO, Xu C, Shen G et al (2008) Activation of Nrf2-antioxidant signaling attenuates NF-κB-inflammatory response and elicits apoptosis. Biochem Pharmacol 76:1485–1489PubMedCrossRefGoogle Scholar
  58. Lian F, Wang XD (2008) Enzymatic metabolites of lycopene induce Nrf2-mediated expression of phase II detoxifying/antioxidant enzymes in human bronchial epithelial cells. Int J Cancer 123:1262–1268PubMedCrossRefGoogle Scholar
  59. Liu RH (2004) Potential synergy of phytochemicals in cancer prevention: mechanism of action. J Nutr 134:3479S–3485SPubMedGoogle Scholar
  60. Maher J, Yamamoto M (2010) The rise of antioxidant signaling-the evolution and hormetic actions of Nrf2. Toxicol Appl Pharmacol 244:4–15PubMedCrossRefGoogle Scholar
  61. Manson MM, Gescher A, Hudson EA et al (2000) Blocking and suppressing mechanisms of chemoprevention by dietary constituents. Toxicol Lett 112:499–505PubMedCrossRefGoogle Scholar
  62. Martín MA, Ramos S, Granado-Serrano AB, Rodríguez-Ramiro I et al (2010) Hydroxytyrosol induces antioxidant/detoxificant enzymes and Nrf2 translocation via extracellular regulated kinases and phosphatidylinositol-3-kinase/protein kinase B pathways in HepG2 cells. Mol Nutr Food Res 54:956–966PubMedCrossRefGoogle Scholar
  63. Moolgavkar SH (1978) The multistage theory of carcinogenesis and the age distribution of cancer in man. J Natl Cancer Inst 61:49–52PubMedGoogle Scholar
  64. Nair HB, Sung B, Yadav VR et al (2010) Delivery of antiinflammatory nutraceuticals by nanoparticles for the prevention and treatment of cancer. Biochem Pharmacol 80:1833–1843PubMedCrossRefGoogle Scholar
  65. Nakamura Y, Yoshida C, Murakami A, Ohigashi H et al (2004) Zerumbone, a tropical ginger sesquiterpene, activates phase II drug metabolizing enzymes. FEBS Lett 572:245–250PubMedCrossRefGoogle Scholar
  66. Nguyen T, Nioi P, Pickett CB (2009) The Nrf2-antioxidant response element signaling pathway and its activation by oxidative stress. J Biol Chem 284:13291–13295PubMedCrossRefGoogle Scholar
  67. Niestroy J, Barbara A, Herbst K, Rode S et al (2011) Single and concerted effects of benzo[a]pyrene and flavonoids on the AhR and Nrf2-pathway in the human colon carcinoma cell line Caco-2. Toxicol In Vitro 25:671–683PubMedCrossRefGoogle Scholar
  68. Palmer HJ, Paulson KE (1997) Reactive oxygen species and antioxidants in signal transduction and gene expression. Nutr Rev 55:479–489Google Scholar
  69. Primiano T, Kensler TW, Kuppusamy P, Zweier JL et al (1996) Induction of hepatic hemeoxygenase-1 ferritin in rats by cancer chemopreventive dithiolethiones. Carcinogenesis 17:2291–2296PubMedCrossRefGoogle Scholar
  70. Prince M, Li Y, Childers A, Itoh K et al (2009) Comparison of citrus coumarins on carcinogen-detoxifying enzymes in Nrf2 knockout mice. Toxicol Lett 185:180–186PubMedCrossRefGoogle Scholar
  71. Priya DKD, Gayathri R, Sakthisekaran D (2011) Role of sulforaphane in the anti-initiating mechanism of lung carcinogenesis in vivo by modulating the metabolic activation and detoxification of benzo(a)pyrene. Biomed Pharmacother 65:9–16CrossRefGoogle Scholar
  72. Ross SA (2010) Evidence for the relationship between diet and cancer. Exp Oncol 32:137–142PubMedGoogle Scholar
  73. Rubiolo JA, Mithieux G, Vega FV (2008) Resveratrol protects primary rat hepatocytes against oxidative stress damage: activation of the Nrf2 transcription factor and augmented activities of antioxidant enzymes. Eur J Pharmacol 591:66–72PubMedCrossRefGoogle Scholar
  74. Sahin K, Orhan C, Akdemir F, Tuzcu M et al (2011) Resveratrol protects quail hepatocytes against heat stress: modulation of the Nrf2 transcription factor and hear shock proteins. J Anim Physiol Anim Nutr. doi:10.1111/j.1439-0396.2010.01123.x, PMID: 21244525Google Scholar
  75. Scapagnini G, Sonya V, Nader AG, Calogero C et al (2011) Modulation of Nrf2/ARE pathway by food polyphenols: a nutritional neuroprotective strategy for cognitive and neurodegenerative disorders. Mol Neurobiol 44(2):192–201, PMID:21499987PubMedCrossRefGoogle Scholar
  76. Schmid HP, Fischer C, Engeler DS, Bendhack ML et al (2011) Nutritional aspects of primary prostate cancer prevention. Recent Results Cancer Res 188:101–107PubMedCrossRefGoogle Scholar
  77. Seeram NP, Adams LS, Henning SM, Niu Y et al (2005) In vitro antiproliferative, apoptotic and antioxidant activities of punicalagin, ellagic acid and a total pomegranate tannin extract are enhanced in combination with other polyphenols as found in pomegranate juice. J Nutr Biochem 16:360–367PubMedCrossRefGoogle Scholar
  78. Shehzad A, Wahid F, Lee YS (2010) Curcumin in cancer chemoprevention: molecular targets, pharmacokinetics, bioavailability and clinical trials. Arch Pharm 343:489–499CrossRefGoogle Scholar
  79. Shen G, Xu C, Hu R, Jain MR et al (2006) Modulation of nuclear factor E2-related factor 2-mediated gene expression in mice liver and small intestine by cancer chemopreventive agent curcumin. Mol Cancer Ther 5:39–51PubMedCrossRefGoogle Scholar
  80. Slocum SL, Kensler TW (2011) Nrf2: control of sensitivity to carcinogens. Arch Toxicol 85:273–284PubMedCrossRefGoogle Scholar
  81. Sporn MB (1991) Carcinogenesis and cancer: different perspectives on the same disease. Cancer Res 51:6215–6218PubMedGoogle Scholar
  82. Sporn MB, Suh N (2000) Chemoprevention of cancer. Carcinogenesis 21:525–530PubMedCrossRefGoogle Scholar
  83. Sporn MB, Suh N (2002) Chemoprevention: an essential approach to controlling cancer. Nat Rev Cancer 2:527–543CrossRefGoogle Scholar
  84. Surh YJ (2008) NF-ĸB and Nrf2 as potential chemopreventive targets of some anti-inflammatory and antioxidative phytonutrients with anti-inflammatory and antioxidative activities. Asia Pac J Clin Nutr 17:269–272PubMedGoogle Scholar
  85. Surh YJ, Kundu JK, Na HK (2008) Nrf2 as a master redox switch in turning on the cellular signaling involved in the induction of cytoprotective genes by some chemopreventive phytochemicals. Planta Med 74:1526–1539PubMedCrossRefGoogle Scholar
  86. Tanigawa S, Fujii M, Hou DX (2007) Action of Nrf2 and Keap1 in ARE-mediated NQO1 expression by quercetin. Free Radic Biol Med 42:1690–1703PubMedCrossRefGoogle Scholar
  87. Tao KS, Wang W, Wang L, Cao DY et al (2008) The multifaceted mechanisms for coffee’s anti-tumorigenic effect on liver. Med Hypotheses 71:730–736PubMedCrossRefGoogle Scholar
  88. Treuba GP, Sanchez GM, Giuliani A (2004) Oxygen free radical and antioxidant defense mechanism in cancer. Front Biosci 9:2029–2044CrossRefGoogle Scholar
  89. Tripathi DN, Jena GB (2010) Astaxanthin intervention ameliorates cyclophosphamide-induced oxidative stress, DNA damage and early hepatocarcinogenesis in rat: role of Nrf2, p53, p38 and phase-II enzymes. Mutat Res 696:69–80PubMedGoogle Scholar
  90. Valko M, Izakovic M, Mazur M, Rhodes CJ (2004) Role of oxygen radicals in DNA damage and cancer incidence. Mol Cell Biochem 266:37–56PubMedCrossRefGoogle Scholar
  91. Valko M, Rhodes CJ, Moncol J, Izaokovic M et al (2006) Free radicals, metals and antioxidants in oxidative stress-induced cancer. Chem Biol Interact 160:1–40PubMedCrossRefGoogle Scholar
  92. Wagner AE, Boesch-Saadatmandi C, Breckwoldt D, Schrader C et al (2011) Ascorbic acid partly antagonizes resveratrol mediated heme oxygenase-1 but not paraoxo-nase-1 induction in cultured hepatocytes – role of the redox-regulated transcription factor Nrf2. BMC Complement Altern Med 11:1–8PubMedGoogle Scholar
  93. Wattenberg LW (1975) Effects of dietary constituents on the metabolism of chemical carcinogens. Cancer Res 35:3326–3331PubMedGoogle Scholar
  94. Wattenberg LW (1985) Chemoprevention of cancer: different perspectives on the same disease. Cancer Res 45:1–8PubMedCrossRefGoogle Scholar
  95. Xu C, Yuan X, Pan Z, Shen G et al (2006) Mechanism of action of isothiocyanates: the induction of ARE-regulated genes is associated with activation of ERK and JNK and the phosphorylation and nuclear translocation of Nrf2. Mol Cancer Ther 5:1918–1926PubMedCrossRefGoogle Scholar
  96. Yeh CT, Yen GC (2005) Effect of sulforaphane on metallothionein expression and induction of apoptosis in human hepatoma HepG2 cells. Carcinogenesis 26:2138–2148PubMedCrossRefGoogle Scholar
  97. Yeh CT, Yen GC (2006) Involvement of p38 MAPK and Nrf2 in phenolic acid-induced P-form phenol sulfotransferase expression in human hepatoma HepG2 cells. Carcinogenesis 27:1008–1017PubMedCrossRefGoogle Scholar
  98. Yuan JH, Li YQ, Yang XY (2007) Inhibition of epigallocatechin gallate on orthotopic colon cancer by unregulating the Nrf2-UGT1A signal pathway in nude mice. Pharmacology 80:269–278PubMedCrossRefGoogle Scholar
  99. Yuan JH, Li YQ, Yang XY (2008) Protective effects of epigallocatechin gallate on colon preneoplastic lesions induced by 2-amino-3-methylimidazo[4,5-f]quinolone in mice. Mol Med 14:590–598PubMedCrossRefGoogle Scholar
  100. Zhang Y, Munday R (2008) Dithiolethiones for cancer chemoprevention: where do we stand? Mol Cancer Ther 7:3470–3479PubMedCrossRefGoogle Scholar
  101. Zhang Z, Yang X, Yuan J, Zi S et al (2009) Modulation of Nrf2 and UGT1A expression by epigallocatechin-3-gallate in colon cancer cells and BALB/c mice. Chin Med J 122:1660–1665PubMedGoogle Scholar
  102. Zhao CR, Gao ZH, Qu XJ (2010) Nrf2-ARE signaling pathway and natural products for cancer chemoprevention. Cancer Epidemiol 34:523–533PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media B.V. 2012

Authors and Affiliations

  1. 1.Department of Pharmaceutical SciencesCollege of Pharmacy, Northeast Ohio Medical UniversityRootstownUSA
  2. 2.Department of Pharmaceutical and Administrative SciencesSchool of Pharmacy, American University of Health SciencesSignal HillUSA

Personalised recommendations